UCB SA (UCBb)

72.35
-0.52(-0.71%)
  • Volume:
    171
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    72.35 - 72.35
Trading near 52-week Low

UCBb Overview

Prev. Close
72.87
Day's Range
72.35-72.35
Revenue
-
Open
72.35
52 wk Range
72.35-116.1
EPS
4.68
Volume
171
Market Cap
13.83B
Dividend (Yield)
0.91
(1.24%)
Average Volume (3m)
94,345
P/E Ratio
16.14
Beta
0.394
1-Year Change
-25.89%
Shares Outstanding
189,958,817
Next Earnings Date
01 Nov 2022
What is your sentiment on UCB?
or
Vote to see community's results!

UCB SA News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

UCB SA Company Profile

UCB SA Company Profile

Employees
8284
Market
Belgium
  • Type:Equity
  • Market:Belgium
  • ISIN:BE0003739530

Ucb SA is a Belgium-based biopharmaceutical and specialty chemical company that specializes in two therapeutic areas: diseases of the central nervous system (CNS) and immunology. In the area of central nervous system disorders, the Company is focused on epilepsy, diabetic neuropathic pain, multiple sclerosis, fibromyalgia, restless legs syndrome and Parkinson’s disease, and the area of immunology includes, bone loss disorders, Crohn’s disease, rheumatoid arthritis and respiratory disease. In addition to its core fields of business, Ucb SA delivers molecule solutions to specialists for use in the treatment of severe diseases. Its product portfolio includes drugs, such as Neupro, Vimpat, Cimzia, among others. Ucb SA also operates in primary care to support specialist products that are administered by primary care physicians.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell